Brief

On February 14, 2025, the National Agency for Food, Environmental and Occupational Health Safety (ANSES) issued an update regarding ANSES offers to classify resorcinol as an endocrine disruptor in the European CLP regulation. This proposal is based on evidence that resorcinol impacts thyroid function, with harmful effects, and aligns with the recent addition of this classification category in the CLP regulation.

This content is restricted.

Highlights content goes here...

This content is restricted.

National Agency for Food, Environmental and Occupational Health Safety (ANSES)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies